Nautica Enterprises Aktie
WKN DE: 888348 / ISIN: US6390891017
|
28.10.2025 13:35:59
|
Nautilus Biotechnology, Inc. Q3 Loss Decreases, Beats Estimates
(RTTNews) - Nautilus Biotechnology, Inc. (NAUT) released Loss for third quarter that decreased from last year and beat the Street estimates.
The company's bottom line totaled -$13.57 million, or -$0.11 per share. This compares with -$16.45 million, or -$0.13 per share, last year.
Analysts on average had expected the company to earn -$0.16 per share. Analysts' estimates typically exclude special items.
Nautilus Biotechnology, Inc. earnings at a glance (GAAP) :
-Earnings: -$13.57 Mln. vs. -$16.45 Mln. last year. -EPS: -$0.11 vs. -$0.13 last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Nautica Enterprises Inc.mehr Nachrichten
| Keine Nachrichten verfügbar. |